Klein, D. B., & Tabarrok, A. (2008). Do Off-Label Drug Practices Argue Against FDA Efficacy Requirements? A Critical Analysis of Physicians' Argumentation for Initial Efficacy Requirements. American Journal of Economics & Sociology, 67(5), 743-776.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Klein, Daniel B., y Alexander Tabarrok. "Do Off-Label Drug Practices Argue Against FDA Efficacy Requirements? A Critical Analysis of Physicians' Argumentation for Initial Efficacy Requirements."
American Journal of Economics & Sociology 67, no. 5 (2008): 743-776.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Klein, Daniel B., y Alexander Tabarrok. "Do Off-Label Drug Practices Argue Against FDA Efficacy Requirements? A Critical Analysis of Physicians' Argumentation for Initial Efficacy Requirements."
American Journal of Economics & Sociology, vol. 67, no. 5, 2008, pp. 743-776.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.